Progressive Care Closes October With Strong Year-O
Post# of 1525
Posted On: 11/19/2015 5:04:31 PM
Progressive Care Closes October With Strong Year-Over-Year Performance
MIAMI, FL--(Marketwired - November 17, 2015) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME"
and the supply of prescription medications to long term care facilities, announces strong October sales.
The pharmacy filled approximately 16,000 prescriptions during the month of October, which is a 20% increase over the same month last year. Pharmacy revenues also remained steady at nearly $1.2 million. The Company has been able to continue producing consistent results throughout the year despite ongoing changes to pharmacy industry.
"The industry is constantly in a state of flux as new therapies are added and best practices revised," acknowledged Shital Parikh Mars, COO. "But PharmCo has been able to achieve consistent performance throughout the year regardless of the changes due to active forethought on the impact of new developments and strong relationships with providers and insurance carriers who rely on PharmCo's unique approach to pharmaceutical services. We believe that our position as a leader in pharmacy services will propel us further as we close out the year."
About Progressive Care
Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment and the supply of prescription medications to long term care facilities.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target", "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements
MIAMI, FL--(Marketwired - November 17, 2015) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME"
and the supply of prescription medications to long term care facilities, announces strong October sales. The pharmacy filled approximately 16,000 prescriptions during the month of October, which is a 20% increase over the same month last year. Pharmacy revenues also remained steady at nearly $1.2 million. The Company has been able to continue producing consistent results throughout the year despite ongoing changes to pharmacy industry.
"The industry is constantly in a state of flux as new therapies are added and best practices revised," acknowledged Shital Parikh Mars, COO. "But PharmCo has been able to achieve consistent performance throughout the year regardless of the changes due to active forethought on the impact of new developments and strong relationships with providers and insurance carriers who rely on PharmCo's unique approach to pharmaceutical services. We believe that our position as a leader in pharmacy services will propel us further as we close out the year."
About Progressive Care
Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment and the supply of prescription medications to long term care facilities.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target", "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements
(0)
(0)Progressive Care Inc. (RXMD) Stock Research Links
Scroll down for more posts ▼